| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.4438 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.4905 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5059 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5444 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5509 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5612 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5710 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5818 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5850 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5878 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5937 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5959 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.5968 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6003 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6324 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6327 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6387 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6396 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6412 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6461 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6520 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6730 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.6848 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7001 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7227 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7353 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7437 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7467 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7618 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7755 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.7966 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8152 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8276 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8561 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8632 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8700 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8748 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8755 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8807 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.8960 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9012 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9051 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9244 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9322 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9421 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9518 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9575 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9587 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9658 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9680 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9812 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9949 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 0.9981 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0019 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0229 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0242 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0273 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0300 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0344 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0534 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0589 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0669 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0713 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0886 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.0956 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1046 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1047 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1167 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1297 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1323 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1353 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.1363 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2070 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2133 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2206 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2264 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2407 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2703 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2705 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2714 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2848 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.2892 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3332 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3444 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3491 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3643 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3696 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3766 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3875 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3879 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3910 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.3961 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4032 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4077 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4502 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4718 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4759 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4846 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.4911 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.5063 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.5144 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.6002 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.6457 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.7734 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.7765 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 1-stearoyl-GPC (18:0) | 1.7896 | Peak area | Diabetic non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|